Lili Yang.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 35522101.
- Also identified by DOI 10.1016/j.xcrm.2022.100616 and PMC identifier 9460952.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lili Yang is an associate professor of microbiology, immunology, and molecular genetics at the University of California, Los Angeles (UCLA). She and her colleagues developed allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy. In this Q&A, she describes her research journey and her opinions about the cancer immunotherapy research field.
Medical subject headings
- Natural Killer T-Cells
- Neoplasms